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Case Report
Abstract
Because the prognosis of the patients with pancreatic cancer is very poor, there are few opportunities to perform surgery for
pulmonary metastasis. Here we report the resection of a solitary pulmonary metastasis from pancreatic cancer, appearing as
thin-walled cavity, which appeared 5 years after pancreaticoduodenectomy. Although the present patient underwent incom-
plete resection because of malignant pleural effusion and pleural dissemination, he is currently still alive without evident re-
currence at 18 months after surgery.
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Introduction
The prognosis of patients with advanced pancreatic cancer is
still poor and there are few opportunities to perform surgery
for pulmonary metastasis of pancreatic cancer.1, 2, 3 We have
experienced a rare case of solitary pulmonary metastasis pre-
senting as a thin-walled cavity, which emerged 5 years after
initial surgery and the patient is currently alive without evi-
dent recurrence at one year and 6 months after surgery in-
stead of malignant pleural effusion and pleural dissemina-
tion.
Case presentation
A 70-year-old male was referred to our hospital because of a
pulmonary thin-walled cavity lesion. He had undergone
pancreaticoduodenectomy for pancreatic cancer 5 years pre-
viously, when histological examination had revealed stage 4b
disease with paraaortic lymph node metastasis. Despite ad-
juvant chemotherapy with gemcitabine for 1 years after sur-
gery, the level of CA19-9 had increased and liver metastasis
had appeared. TS-1 was then administered for 2 years, and
this led to disappearance of the liver metastasis and decrease
of CA19-9 to a normal level. For 2 years thereafter, the pa-
tient had been followed up by routine chest and abdominal
CT without any treatment due to severe TS-1 related derma-
titis. At 2 years after withdrawal of TS-1, a thin walled cavity
lesion had appeared in the lower lobe of the right lung, and
this had gradually increased in size. He was then referred to
our hospital for further examination.
Chest CT on admission demonstrated a thin-walled cavity
lesion about 27 mm in diameter in the right lower lobe.
(Figure 1A, 1B) The patient was a smoker, with a pack-year
index of 90. The levels of tumor markers (carcinoembryonic
antigen, Cyfra and CA19-9) on admission were within nor-
mal limits. Routine blood counts and other biochemical pa-
rameters were also within normal limits. Transbronchial
biopsy under bronchofiberscope guidance was unable to
provide a clear diagnosis. Because the possibility of primary
lung cancer could not be excluded, thoracoscopic surgery
was performed. This revealed mild serous pleural effusion
and multiple small white nodules on the visceral and parietal
pleura. (Figure 1C, 1D) Cytological and histological exami-
nation showed malignant cells in pleural effusion and small
white nodules. We performed video-assisted thoracoscopic
wedge resection of the lung and intrathoracic administration
of cisplatin. Histological examination of the resected lung
mass demonstrated proliferation of large, clear columnar
epithelial cells with nuclear atypia arranged in atypical
glandular structures. Immunohistochemical staining of CK7
and CA19-9 was positive, CK20 was slightly positive, and
TTF-1 and NapsinA was negative. (Figure 2) On this basis,
the tumor was diagnosed as metastatic adenocarcinoma from
pancreatic cancer. The patient was discharged from hospital
3 days after surgery without any postoperative complications.
After 2 months of TS-1 administration following surgery, he
has been followed up at local hospital. One year and 6 month
after surgery, he still alive without evident recurrence.
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FIG. 1: Chest computed tomography on admission demonstrated a
thin-walled cavity lesion about 27 mm in diameter in the right low-
er lobe with peripheral tissue indentation. (a: axial view, b: coronal
view) Intraoperative video-assisted thoracoscopic image demon-
strated dissemination of metastatic pancreatic cancer. (c: dissemina-
tion at parietal pleura, d: dissemination at visceral pleura).
FIG. 2: Histological examination of the resected lung tumor demon-
strated proliferation of large, clear columnar epithelial cells with
nuclear atypia arranged in atypical glandular structures (a: H-E stain
×100). Immunohistochemical staining of CK7 (b) and CA19-9 (c)
was positive, CK20 (d) was slightly positive, and TTF-1 (e) and Nap-
sinA (f) was negative.
Discussion
It has been reported that 92% of cavity lesion with a wall
thickness of less than 4mm are benign disorders.4 Although
primary lung cancer often shows cavity formation within the
tumor, this feature is rare in cases of pulmonary metastasis
from cancers in other organs. Most reported metastatic pul-
monary lesions showing cavities have originated form head
and neck sarcoma or colon cancer.5 Solitary pulmonary me-
tastasis of pancreatic cancer presenting a thin-walled cavity
was not reported previously. In this present case, CT findings
suggested a primary lung carcinoma or infectious disease, as
the lesion was a solitary cavity with a wall less than 4 mm
thick and slight peripheral tissue indentation.
The prognosis of advanced pancreatic cancer is still poor, and
the median survival for patients after pancreatic resection is
12.6 months. Among patients who undergo surgical resec-
tion, the majority die due to disease recurrence, with a
3-year disease-free survival rate of only 27%.1 Because ve-
nous blood from the pancreas flowed into portal system,
distant metastasis of pancreatic cancer usually appeared in
liver and peritoneal cavity, and lung metastasis is rare, with a
reported incidence of 6.4%.6 Moreover, most patients with
lung metastasis from pancreatic cancer are not considered for
surgical treatment because of coexisting involvement of oth-
er organs or multiple lung tumors. Therefore, resection of
lung metastasis from pancreatic cancer is performed very
rarely, and reported in only a few cases.1, 2 In this present
case, because liver metastasis had completely regressed after
chemotherapy, no form of organ involvement other than
that of the lung was evident on admission, and preoperative
CT findings suggested a primary lung carcinoma or infec-
tious disease, the patient underwent surgical treatment.
Some reports have documented long-term survival after
complete resection of pulmonary metastasis from pancreatic
cancer.1 Although the present patient underwent incomplete
resection because of malignant pleural effusion and pleural
dissemination, he is currently still alive without evident
recurrence at 18 months after surgery. In this case, multi-
modality treatment including resection of solitary pulmo-
nary nodule, intrathoracic administration of anti-cancer
drug and postoperative chemotherapy may be effective for
the treatment of lung metastasis of pancreatic cancer with
malignant pleural effusion and dissemination. If patients
with pancreatic cancer have solitary pulmonary metastasis
without involvement of other organs, surgical resection may
be feasible.
Although intraoperative histological examination did not
provide a precise diagnosis, postoperative immunohisto-
chemical staining demonstrated that the lesion was a metas-
tasis from pancreatic cancer. Immunohistochemical staining
of CK7 and CA19-9, which are usually positive in pancreatic
cancer, gave a positive result, and CK20 was also slightly
positive, whereas TTF-1 and NapsinA, which are usually
positive in lung cancer, were negative. Immunohistochemi-
cal staining was useful to distinguishing between lung me-
tastasis of pancreatic cancer and primary lung carcinoma.
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Conclusion
In conclusion, we have described a rare case of solitary pul-
monary metastasis with a thin-walled cavity arising 5 years
after pancreaticoduodenectomy for pancreatic cancer.
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